This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:29, 10 November 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII', 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:29, 10 November 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII', 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.002.493 |
Chemical and physical data | |
Formula | C7H5BiO6 |
Molar mass | 394.091 g·mol g·mol |
3D model (JSmol) | |
Density | 1.1 g/cm |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Bismuth subgallate, with a chemical formula C7H5BiO6, is the active ingredient in Devrom (internal deodorant), an over-the-counter FDA-approved medicine commonly used to treat malodor by deodorizing flatulence and stool. Also, it has been used to treat Helicobacter pylori infection and is used in wound therapy. As an internal deodorant, it is commonly used by individuals who have had ostomy surgery, bariatric surgery, fecal incontinence, and irritable bowel syndrome.
It can cause darkening of the tongue and stools, which is temporary and harmless. A reversible encephalopathy was noted and examined in a few subjects taking bismuth subgallate.
Safety
It is quite nontoxic, but it may cause minor irritation.
See also
External links
- American Cancer Society: Ileostomy Guide
- Cleveland Clinic-Having an Ileostomy– A Primer for New Ostomates
- United Ostomy Association of America-Ileostomy Guide
- The Ostomy Files:The Issue of Oral Medications and a Fecal Ostomy
- Devrom website
References
- Gorbach S. L. (1990). "Bismuth therapy in gastrointestinal diseases". Gastroenterology. 99 (3): 863–75. PMID 2199292.
- Burns R., Thomas D. W., Barron V. J. (1974). "Reversible encephalopathy possibly associated with bismuth subgallate ingestion". British Medical Journal. 9 (1): 220–3. PMC 1633100. PMID 4818163.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)